|
1
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasche B: Role of transforming growth
factor beta in cancer. J Cell Physiol. 186:153–168. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miettinen PJ, Ebner R, Lopez AR and
Derynck R: TGF-beta induced transdifferentiation of mammary
epithelial cells to mesenchymal cells: Involvement of type I
receptors. J Cell Biol. 127:2021–2036. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar
|
|
6
|
Roberts AB, Tian F, Byfield SD, Stuelten
C, Ooshima A, Saika S and Flanders KC: Smad3 is key to
TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,
tumor suppression and metastasis. Cytokine Growth Factor Rev.
17:19–27. 2006. View Article : Google Scholar
|
|
7
|
Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu
Z, Zhao J and Zhang HT: JAK/STAT3 signaling is required for
TGF-β-induced epithelial-mesenchymal transition in lung cancer
cells. Int J Oncol. 44:1643–1651. 2014.PubMed/NCBI
|
|
8
|
Yan Z, Winawer S and Friedman E: Two
different signal transduction pathways can be activated by
transforming growth factor beta 1 in epithelial cells. J Biol Chem.
269:13231–13237. 1994.PubMed/NCBI
|
|
9
|
Edlund S, Landström M, Heldin CH and
Aspenström P: Transforming growth factor-beta-induced mobilization
of actin cytoskeleton requires signaling by small GTPases Cdc42 and
RhoA. Mol Biol Cell. 13:902–914. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bakin AV, Tomlinson AK, Bhowmick NA, Moses
HL and Arteaga CL: Phosphatidylinositol 3-kinase function is
required for transforming growth factor beta-mediated epithelial to
mesenchymal transition and cell migration. J Biol Chem.
275:36803–36810. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Turck CM, Teumer JK and Stavnezer E:
Unique sequence, ski, in Sloan-Kettering avian retroviruses with
properties of a new cell-derived oncogene. J Virol. 57:1065–1072.
1986.PubMed/NCBI
|
|
12
|
Akiyoshi S, Inoue H, Hanai J, Kusanagi K,
Nemoto N, Miyazono K and Kawabata M: c-Ski acts as a
transcriptional co-repressor in transforming growth factor-beta
signaling through interaction with smads. J Biol Chem.
274:35269–35277. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo K, Stroschein SL, Wang W, Chen D,
Martens E, Zhou S and Zhou Q: The Ski oncoprotein interacts with
the Smad proteins to repress TGFbeta signaling. Genes Dev.
13:2196–2206. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu W, Angelis K, Danielpour D, Haddad MM,
Bischof O, Campisi J, Stavnezer E and Medrano EE: Ski acts as a
co-repressor with Smad2 and Smad3 to regulate the response to type
beta transforming growth factor. Proc Natl Acad Sci USA.
97:5924–5929. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferrand N, Atfi A and Prunier C: The
oncoprotein c-Ski functions as a direct antagonist of the
transforming growth factor-β type I receptor. Cancer Res.
70:8457–8466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Band AM, Björklund M and Laiho M: The
phosphatidylinositol 3-kinase/Akt pathway regulates transforming
growth factor-β signaling by destabilizing ski and inducing Smad7.
J Biol Chem. 284:35441–35449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Li P, Zhang Y, Li GB, Zhou YG, Yang
K and Dai SS: c-Ski inhibits the proliferation of vascular smooth
muscle cells via suppressing Smad3 signaling but stimulating p38
pathway. Cell Signal. 25:159–167. 2013. View Article : Google Scholar
|
|
18
|
Luo K: Ski and SnoN: Negative regulators
of TGF-beta signaling. Curr Opin Genet Dev. 14:65–70. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reed JA, Bales E, Xu W, Okan NA,
Bandyopadhyay D and Medrano EE: Cytoplasmic localization of the
oncogenic protein Ski in human cutaneous melanomas in vivo:
Functional implications for transforming growth factor beta
signaling. Cancer Res. 61:8074–8078. 2001.PubMed/NCBI
|
|
20
|
Fukuchi M, Nakajima M, Fukai Y, Miyazaki
T, Masuda N, Sohda M, Manda R, Tsukada K, Kato H and Kuwano H:
Increased expression of c-Ski as a co-repressor in transforming
growth factor-beta signaling correlates with progression of
esophageal squamous cell carcinoma. Int J Cancer. 108:818–824.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Buess M, Terracciano L, Reuter J,
Ballabeni P, Boulay JL, Laffer U, Metzger U, Herrmann R and
Rochlitz C: Amplification of SKI is a prognostic marker in early
colorectal cancer. Neoplasia. 6:207–212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heider TR, Lyman S, Schoonhoven R and
Behrns KE: Ski promotes tumor growth through abrogation of
transforming growth factor-beta signaling in pancreatic cancer. Ann
Surg. 246:61–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ritter M, Kattmann D, Teichler S, Hartmann
O, Samuelsson MK, Burchert A, Bach JP, Kim TD, Berwanger B, Thiede
C, et al: Inhibition of retinoic acid receptor signaling by Ski in
acute myeloid leukemia. Leukemia. 20:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shinagawa T, Nomura T, Colmenares C, Ohira
M, Nakagawara A and Ishii S: Increased susceptibility to
tumorigenesis of ski-deficient heterozygous mice. Oncogene.
20:8100–8108. 2001. View Article : Google Scholar
|
|
25
|
Wang P, Chen Z, Meng ZQ, Fan J, Luo JM,
Liang W, Lin JH, Zhou ZH, Chen H, Wang K, et al: Dual role of Ski
in pancreatic cancer cells: Tumor-promoting versus
metastasis-suppressive function. Carcinogenesis. 30:1497–1506.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Derynck R and Akhurst RJ: Differentiation
plasticity regulated by TGF-beta family proteins in development and
disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massagué J: TGFbeta in Cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lei Z, Liu RY, Zhao J, Liu Z, Jiang X, You
W, Chen XF, Liu X, Zhang K, Pasche B, et al: TGFBR1 haplotypes and
risk of non-small-cell lung cancer. Cancer Res. 69:7046–7052. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Colmenares C and Stavnezer E: The ski
oncogene induces muscle differentiation in quail embryo cells.
Cell. 59:293–303. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakao T, Kurita N, Komatsu M, Yoshikawa K,
Iwata T, Utsunomiya T and Shimada M: Expression of thrombospondin-1
and Ski are prognostic factors in advanced gastric cancer. Int J
Clin Oncol. 16:145–152. 2011. View Article : Google Scholar
|
|
32
|
Kiyono K, Suzuki HI, Morishita Y, Komuro
A, Iwata C, Yashiro M, Hirakawa K, Kano MR and Miyazono K: c-Ski
overexpression promotes tumor growth and angiogenesis through
inhibition of transforming growth factor-beta signaling in
diffuse-type gastric carcinoma. Cancer Sci. 100:1809–1816. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Le Scolan E, Zhu Q, Wang L, Bandyopadhyay
A, Javelaud D, Mauviel A, Sun L and Luo K: Transforming growth
factor-beta suppresses the ability of Ski to inhibit tumor
metastasis by inducing its degradation. Cancer Res. 68:3277–3285.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Javelaud D, van Kempen L, Alexaki VI, Le
Scolan E, Luo K and Mauviel A: Efficient TGF-β/SMAD signaling in
human melanoma cells associated with high c-SKI/SnoN expression.
Mol Cancer. 10:22011. View Article : Google Scholar
|
